(2023)
Personalized Antiviral Drug Selection in Patients With Chronic Hepatitis B Using a Machine Learning Model: A Multinational Study.
AMERICAN JOURNAL OF GASTROENTEROLOGY.
118,
11
(2023)
The effects of moderate alcohol consumption on non-alcoholic fatty liver disease.
CLINICAL AND MOLECULAR HEPATOLOGY.
29,
supp1
(2023)
Isolated Hepatitis B Core Antibody Positivity and Long-Term Liver-Related Mortality in Korea: A Cohort Study.
AMERICAN JOURNAL OF GASTROENTEROLOGY.
118,
1
(2022)
Effectiveness of entecavir vs tenofovir disoproxil fumarate for functional cure of chronic hepatitis B in an international cohort.
HEPATOLOGY INTERNATIONAL.
16,
6
(2022)
Effect of L-carnitine on quality of life in covert hepatic encephalopathy: a randomized, double-blind, placebo-controlled study.
KOREAN JOURNAL OF INTERNAL MEDICINE.
37,
4
(2022)
Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B.
Clinical Gastroenterology and Hepatology.
20,
6
(2022)
Liver Fibrosis in Asians With Metabolic Dysfunction–Associated Fatty Liver Disease.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY.
20,
5
(2022)
Progression Rates by Age, Sex, Treatment, and Disease Activity by AASLD and EASL Criteria: Data for Precision Medicine.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY.
20,
4
(2022)
A Multi-Center, Double-Blind Randomized Controlled Phase III Clinical Trial to Evaluate the Antiviral Activity and Safety of DA-2802 (Tenofovir Disoproxil Orotate) and Viread (Tenofovir Disoproxil Fumarate) in Chronic Hepatitis B Patients.
JOURNAL OF KOREAN MEDICAL SCIENCE.
37,
11
(2022)
Longitudinal renal changes in chronic hepatitis B patients treated with entecavir versus TDF: a REAL-B study.
HEPATOLOGY INTERNATIONAL.
16,
1
(2022)
An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis B.
JOURNAL OF HEPATOLOGY.
76,
2
(2022)
Non-Inferior Efficacy of Tenofovir Disoproxil to Tenofovir Disoproxil Fumarate in Virologically Suppressed Chronic Hepatitis B Patients.
DRUG DESIGN DEVELOPMENT AND THERAPY.
16,
(2022)
On-treatment gamma-glutamyl transferase predicts the development of hepatocellular carcinoma in chronic hepatitis B patients.
LIVER INTERNATIONAL.
42,
1
(2022)
Liver fibrosis scores and risk of liver-related mortality in young adults with chronic hepatitis B: A cohort study.
JOURNAL OF VIRAL HEPATITIS.
29,
1
(2022)
Risk of liver fibrosis in patients with prediabetes and diabetes mellitus.
PLOS ONE.
17,
6 June
(2021)
Fasting Ketonuria and the Risk of Incident Nonalcoholic Fatty Liver Disease With and Without Liver Fibrosis in Nondiabetic Adults.
AMERICAN JOURNAL OF GASTROENTEROLOGY.
116,
11
(2021)
Relationship between gut microbiome diversity and hepatitis B viral load in patients with chronic hepatitis B.
GUT PATHOGENS.
13,
1
(2021)
KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease.
CLINICAL AND MOLECULAR HEPATOLOGY.
27,
3
(2021)
Twelve-month post-treatment parameters are superior in predicting hepatocellular carcinoma in patients with chronic hepatitis B.
LIVER INTERNATIONAL.
41,
7
(2021)
Continuing besifovir dipivoxil maleate versus switching from tenofovir disoproxil fumarate for treatment of chronic hepatitis B: Results of 192-week phase 3 trial.
CLINICAL AND MOLECULAR HEPATOLOGY.
27,
2
(2017)
ASSOCIATION BETWEEN METABOLIC SYNDROME AND LIVER STIFFNESS MEASURED BY MRE IN NAFLD.
GUT AND LIVER.
KOREA, REPUBLIC OF
(2017)
Gender difference in NAFLD.
kOREAN DIGESTIVE DISEASE WEEK 2017.
KOREA, REPUBLIC OF
(2017)
NAFLD AND ALCOHOLIC LIVER DISEASE.
THE LIVER WEEK 2017.
KOREA, REPUBLIC OF
(2017)
THE SEVERITY OF NAFLD ASSOCIATED WITH INSULIN RESISTQNCE AND METABOLIC SYNDROME.
GUT AND LIVER.
KOREA, REPUBLIC OF
(2017)
TrK C IS ESSENTIAL FOR TUMORIGENESIS AND METASTASIS IN HCC.
GUT AND LIVER.
KOREA, REPUBLIC OF
(2017)
association beteween metabolic syndrome and hepatic fat measured by MRI in NAFLD.
대한 내과학회 추계학술대회.
KOREA, REPUBLIC OF
(2017)
ASSOCIATION BETWEEN METABOLIC SYNDROME AND LIVER STIFFNESS MEASURED BY MRE IN NAFLD PATIENTS.
J GASTROINTESTINAL DIG SYSTEM 7:5.
UNITED STATES
(2017)
THE SEVERITY OF NAFLD ASSOCATED WITH INSULIN RESISTANCE AND METABOLIC SYND.
NAFLD SUMMIT.
ITALY
(2017)
EMERGING DRUG THERAPY IN NASH PATIENTS.
명지 국제 간 심포지움.
KOREA, REPUBLIC OF
(2017)
IMPACT OF CLINICALLY SIGNIFICANT PORTAL HYPERTENSION ON THE CLINICAL OUTCOMES IN PATIENTS WITH HCC TREATED BY TACE.
LIVER WEEK 2017.
KOREA, REPUBLIC OF
(2017)
PROSPECTIVE MULTICENTER STUDY TO EVALUATE THE EFFICACY OF TERLIPRESSIN AND ALBUMIN IN CIRRHOTIC PATIENTS WITH ACUTE KIDNEY INJURY.
KASL.
KOREA, REPUBLIC OF
(2017)
difference of thrombocytopenia between alcoholic and viral liver cirrhosis.
LIVER WEEK 2017.
KOREA, REPUBLIC OF
(2017)
Non alcoholic fatty liver disease non invasive fibrosis indices and motality : a cohort study.
Liver week 2017.
KOREA, REPUBLIC OF
(2017)
Validation of usefulness for korean paper and pencil test and computer based Stroop test to detect
minimal hepatic encephalopathy in korea.
Liver week 2017.
KOREA, REPUBLIC OF
(2017)
safety and efficiacy Besifovir in treatment - naive chronic hepatitis virus infection : Randomized double blind double dummy phase 3 study.
Liver week 2017.
KOREA, REPUBLIC OF
(2017)
TrKC IS ESSNTIAL FOR TUMORIGENESIS AND METASTASIS IN HCC.
ASIAN PACIFIC PRIMARY LIVER CANCER EXPERT MEETING 2017.
SINGAPORE
(2017)
건진 코호트 데이터를 이용한 비알코올 지방간 질환 및 대사질환 연구 경험.
korean J Gastroenterology.
KOREA, REPUBLIC OF